Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Your doctor will show you how to use your pen before your first dose ... or at the front of your thigh. If you use Ozempic and insulin, inject them as separate injections. You should not mix ...

Originally approved for type 2 diabetes management, Ozempic has shown promising results in improving insulin sensitivity and addressing metabolic dysfunction. SaveHealth, a prescription discount ...